A Clinical Study of Ivonescimab in Combination With Cadonilimab or Ipilimumab for Advanced Renal Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study aims to evaluate the safety and efficacy of Ivonescimab alone or in combination with Cadonilimab or Ipilimumab in the treatment of advanced clear cell renal cell carcinoma (ccRCC).
Epistemonikos ID: 669d7f926baf5c4fe7143f96186ef8b394ae4ee7
First added on: Oct 17, 2026